![]()
Obesity Treatment Devices Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
The global Obesity Treatment Devices market is expected to experience significant growth, driven by the increasing prevalence of obesity worldwide. The market is projected to reach a size of $2.6 billion by 2027, with a compound annual growth rate of 9.3%. Key market players include Medtronic, Johnson & Johnson, and Apollo Endosurgery. Request Sample Report
◍ Allergan, Inc.
◍ Apollo Endosurgery, Inc.
◍ Aspire Medical, Inc. (Aspire Bariatrics)
◍ Boston Scientific Corp.
◍ Cousin Biotech
◍ CR Bard, Inc.
◍ EnteroMedics, Inc.
◍ GI Dynamics, Inc.
◍ GI Windows, Inc.
◍ Johnson & Johnson
◍ Leptos Biomedical
◍ Mediflex Surgical Products
◍ Medtronic, Inc.
◍ ReShape Medical, Inc.
◍ Satiety, Inc.
◍ Spatz FGIA, Inc.
◍ TransEnterix, Inc.
The obesity treatment devices market is highly competitive, with companies like Allergan, Apollo Endosurgery, and Boston Scientific dominating the industry. These companies offer a range of devices to treat obesity, such as gastric balloons, endoscopic suturing systems, and gastric bands. Sales revenue figures:
- Allergan, Inc.: $15.8 billion
- Boston Scientific Corp.: $9.6 billion
- Medtronic, Inc.: $30.6 billion
Request Sample Report
Hospitals
Clinics ◍ Others
◍ Gastric Banding Systems
◍ Gastric Balloon Systems
◍ Gastric Electrical Stimulation Systems
◍ Gastric Emptying Systems or Gastric Aspiration Systems ◍ Other
Request Sample Report
Request Sample Report
$ X Billion USD